As Chinese and foreign medical device providers target each other's established base, partnership opportunities emerge

Last month, Medtronic announced the opening of a research and development (R&D) center in Beijing, established in collaboration with Shandong Weigao Group. The center will oversee the production of orthopedic products that caters to the Chinese population. Following announcements by GE Healthcare an...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Sinopec announces plans to become China's largest hydrogen energy company in response to China's 14th Five-Year Plan

News Commentary | March 18, 2021

One of Lux's top predictions for 2021 was that China would triple global green hydrogen capacity by 2025. While it remains to be seen where Sinopec plans to fit in China's hydrogen economy, it will start by building 1,000 hydrogen fueling stations by 2025. Lofty claims are common from China, ... To read more, click here.

Chinese government's enabling policies support biopesticides, emerging opportunities for the industry

News Commentary | August 09, 2021

The Chinese government released a series of enabling policies to support research and innovation to promote biopesticides. Some of the measures include providing subsidies for the purchase of plant protection machinery for the application of biopesticies for managing major crop pests. The focus has ... Not part of subscription